1. Home
  2. PLRX vs KPLT Comparison

PLRX vs KPLT Comparison

Compare PLRX & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • KPLT
  • Stock Information
  • Founded
  • PLRX 2015
  • KPLT 2012
  • Country
  • PLRX United States
  • KPLT United States
  • Employees
  • PLRX N/A
  • KPLT N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • KPLT Diversified Commercial Services
  • Sector
  • PLRX Health Care
  • KPLT Consumer Discretionary
  • Exchange
  • PLRX Nasdaq
  • KPLT Nasdaq
  • Market Cap
  • PLRX 89.0M
  • KPLT 97.4M
  • IPO Year
  • PLRX 2020
  • KPLT N/A
  • Fundamental
  • Price
  • PLRX $1.53
  • KPLT $23.07
  • Analyst Decision
  • PLRX Hold
  • KPLT Hold
  • Analyst Count
  • PLRX 10
  • KPLT 1
  • Target Price
  • PLRX $3.93
  • KPLT $10.00
  • AVG Volume (30 Days)
  • PLRX 725.5K
  • KPLT 90.7K
  • Earning Date
  • PLRX 11-06-2025
  • KPLT 11-05-2025
  • Dividend Yield
  • PLRX N/A
  • KPLT N/A
  • EPS Growth
  • PLRX N/A
  • KPLT N/A
  • EPS
  • PLRX N/A
  • KPLT N/A
  • Revenue
  • PLRX N/A
  • KPLT $267,101,999.00
  • Revenue This Year
  • PLRX N/A
  • KPLT $22.88
  • Revenue Next Year
  • PLRX N/A
  • KPLT $10.98
  • P/E Ratio
  • PLRX N/A
  • KPLT N/A
  • Revenue Growth
  • PLRX N/A
  • KPLT 13.04
  • 52 Week Low
  • PLRX $1.10
  • KPLT $5.08
  • 52 Week High
  • PLRX $16.10
  • KPLT $24.34
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 44.68
  • KPLT 69.25
  • Support Level
  • PLRX $1.66
  • KPLT $17.10
  • Resistance Level
  • PLRX $1.85
  • KPLT $24.34
  • Average True Range (ATR)
  • PLRX 0.13
  • KPLT 2.34
  • MACD
  • PLRX -0.02
  • KPLT 0.26
  • Stochastic Oscillator
  • PLRX 12.20
  • KPLT 88.55

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: